Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Jan 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2201961000001117 | Olipudase alfa | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2212231000001113 | Olipudase alfa (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olipudase alfa | Is a | Enzyme agent | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olipudase alfa 20mg powder for solution for infusion vials | Has specific active ingredient | True | Olipudase alfa | Inferred relationship | Existential restriction modifier | |
| Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial | Has specific active ingredient | True | Olipudase alfa | Inferred relationship | Existential restriction modifier | |
| Olipudase alfa 20mg powder for solution for infusion vials 1 vial | Has specific active ingredient | True | Olipudase alfa | Inferred relationship | Existential restriction modifier | |
| Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) | Has specific active ingredient | True | Olipudase alfa | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR